SMA Solar Technology AG (0NIF)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 49.54 |
|---|---|
| 52-week range | 22.58 – 70.70 |
| Return, 1 month / 3 months | −13.8% / −11.1% |
| Return, 1 year / 3 years | +93.3% / −11.9% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 67.4% |
| Worst drawdown (1 year) | -30.0% |
| Average daily value traded | 0.28M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SMA Solar Technology AG makes solar inverters and related equipment for photovoltaic power systems. Its products convert the direct current produced by solar panels into usable alternating current and include inverters for rooftop installations, commercial buildings and large solar power plants, along with monitoring and energy management devices. Customers are mainly solar installers, project developers and operators of solar installations. The company is based in Niestetal, Germany, and serves markets around the world.
The shares are listed on the London Stock Exchange in UK under the code 0NIF, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SMA Solar Technology AG (0NIF) trades on the London Stock Exchange in UK. It last closed at EUR 49.54 on 27 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 2,324 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 93.3% and over the last three months it fell 11.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.0% | ||
| From 52-week high | -27.3% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -11.1% | ||
| 6-month return | -1.5% | ||
| 12-month return, skipping the last month | 124.3% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 67.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.0% | ||
| Liquidity | 40 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.28M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −4.2% |
|---|---|
| 1 month | −13.8% |
| 3 months | −11.1% |
| 6 months | −1.5% |
| 1 year | +93.3% |
| 3 years | −11.9% |
| 5 years | +15.1% |
Signals
| 50-day / 200-day average | 57.10 / 50.57 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 May 2024 | EUR 0.5000 |
| 2 Jun 2021 | EUR 0.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.